BERG Analytics
  • Home
  • Clinical Research, Pharma, BioTech
  • HIT Vendors, Payers and Providers
  • Patient Intelligence™ Platform
  • About
  • Contact Us
  • News
  • Partners
  • Menu
  • Twitter
  • Linkedin
  • Youtube

Artificial Intelligence Accelerates Drug Development for Pharma and Biotech

Target Discovery

bAIcis® is a comprehensive platform for target discovery. We can help you:

  • Initiate novel therapeutic programs de novo
  • Realize commercial value from disparate research data
  • Integrate and analyze molecular high throughput data, low throughput phenotypic data and clinical outcomes
  • Uncover first-in-class molecular targets

Drug Repositioning

By analyzing compound specific molecular data, we can pinpoint applications in human disease:

  • Identify disease pathways targeted by the drug
  • Generate a short number of repositioning hypotheses
  • Point toward relevant in-vitro and in-silico models for hypothesis validation
  • Reveal potential side effects and stratify risks

Complementary Biomarkers

bAIcis® platform can mine your data to discover novel biomarkers with superior predictive power:

  • Intelligently integrate your molecular and patient outcome data
  • Drive toward clinically actionable insight
  • Rescue failing phase III trials by identifying efficacy biomarkers for patient stratification
  • Apply to commercial use clinical biobanks and legacy trial data to move your critical development programs forward

Mechanism of Action

We connect the dots from perturbation to phenotypic to multi-omic disease model data:

  • Infer cause-and-effect molecular mechanisms from high throughput data
  • Spot complex and contextual molecular regulation of disease phenotype
  • Derive actionable insight from volumes of DNA sequencing data
  • Fuse genomics, biochemistry and surrogate disease metrics in-silico

BERG ANALYTICS IS YOUR PARTNER FOR ARTIFICIAL INTELLIGENCE:

‘AI for Clinical Trials’
DOWNLOAD THE OVERVIEW

News

  • Fortune.com: How Big Pharma is Using AI to Make Better DrugsMarch 26, 2018 - 3:09 pm
  • Big Data: Is It Crunch Time for Pharma?September 17, 2017 - 8:32 am
  • AI in Medicine Journal: Berg Analytics Research PaperSeptember 17, 2017 - 8:32 am
  • CEO Niven Narain Discusses AI, AstraZeneca Partnership on BBC’s “Talking Business”September 5, 2017 - 9:40 pm
  • Wall Street Journal: How AI Is Transforming Drug CreationJuly 6, 2017 - 10:14 pm

Events

Current Month

Contact

    BERG Analytics

    • Home
    • Clinical Research, Pharma, BioTech
    • HIT Vendors, Payers and Providers
    • Patient Intelligence™ Platform
    • About
    • Contact Us
    • News
    • Partners
    © Berg, LLC | 500 Old Connecticut Path, Framingham, MA 01701 | 617-588-2239 | Analytics@BERGhealth.com
    • Twitter
    • Linkedin
    • Youtube
    X
    Scroll to top